CORE-008 Cohort A evaluates cretostimogene in BCG‑naive high‑risk #
NMIBC#. Shreyas Joshi, MD, MPH
@WinshipAtEmory joins
@urodocash @UTMDAnderson reviewing CORE-008 Cohort A, reporting early phase 2 results for cretostimogene grenadenorepvec in high-risk BCG-naive NMIBC. #
WatchNow# >
@cgoncology